TDOCTeladoc Health, Inc.

$5.78-27% 1Y

$5.78

$4.4752 weeks$9.71

TDOC in its own filings

Nothing in TDOC's filing record raises a hard flag: no restatement, late filing, bankruptcy or delisting notice, and no auditor change next to one. That is the common case, not a distinction.

247

Events found in the filings · across 1,585 filings · the record starts in 2015

Hard flags: none
Hard flags
Most recent filing: Sep 25, 2026
Most recent filing · Form 8-K
Record starts: Apr 20, 2015
Record starts · the earliest filing Ryufin holds for this name

Details›

Next results filingsame week as a year ago: expected around Oct 28, 2026
SEC comment-letter activity36 occurrences: 2022-10-06

SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.

What the company said

The company's own words from its current reports to the SEC, newest first

Sep 25, 2026On September 24, 2026, Mr. Adam C. Vandervoort, Chief Legal Officer and Secretary of Teladoc Health, Inc. (the "Company"), informed the Company of his decision to resign, effective November 1, 2026.Director or officer change · Form 8-K
Aug 31, 2026Effective August 31, 2026, Teladoc Health, Inc. (the “Company”) hired Michael Grasher as its Chief Financial Officer. Charles Divita, III, who served as the Company’s interim principal financial officer, will continue as Chief Executive Officer.Director or officer change · Form 8-K
Aug 13, 2026On August 10, 2026, Mr. David B. Snow, Jr. notified Teladoc Health, Inc. (the “Company”) of his intention to retire from the Board effective as of September 30, 2026.Director or officer change · Form 8-K
Aug 3, 2026Effective August 3, 2026, the Board of Directors (the “Board”) of Teladoc Health, Inc. (the “Company”) increased the number of directors on the Board to ten and appointed Mark V. Anquillare as a director of the Company.Director or officer change · Form 8-K
Jul 29, 2026Teladoc Health Reports Second Quarter 2026 Results.Earnings release · press release
Apr 29, 2026Teladoc Health Reports First Quarter 2026 Results.Earnings release · press release
Mar 30, 2026Effective March 30, 2026, the Board of Directors (the “Board”) of Teladoc Health, Inc. (the “Company”) increased the number of directors on the Board to nine and appointed Susan R. Salka as a director of the Company.Director or officer change · Form 8-K
Feb 25, 2026Teladoc Health Reports Fourth Quarter and Full Year 2025 Results.Earnings release · press release
Feb 18, 2026Effective February 18, 2026, the Board of Directors (the “Board”) of Teladoc Health, Inc. (the “Company”) increased the number of directors on the Board to ten and appointed Michael S. Smith as a director of the Company.Director or officer change · Form 8-K
Feb 12, 2026On February 8, 2026, Mr. Thomas G. McKinley notified Teladoc Health, Inc. (the “Company”) of his intention to retire from the Board effective as of February 20, 2026.Director or officer change · Form 8-K
Dec 16, 2025On December 11, 2025, Mr. J. Eric Evans notified Teladoc Health, Inc. (the “Company”) of his intention not to stand for reelection at the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”) and to retire from the Board effective as of the conclusion of the Annual Meeting.Director or officer change · Form 8-K